Search research articles
Contact Us
Filters
Showing results (251-260 of 315) with videos related to
Page
of 32
Sort By:
Journal of Diabetes Science and Technology
|
August 10, 2023
Use of Continuous Glucose Monitors in the Hospital: The Diabetes Technology Society Hospital Meeting Report 2023
Tiffany Tian, Rachel E Aaron, Andrea M Yeung, et al.
Molecular Systems Biology
|
November 5, 2017
Pharmacoproteomic characterisation of human colon and rectal cancer
Martin Frejno, Riccardo Zenezini Chiozzi, Mathias Wilhelm, et al.
Diabetes Care
|
April 18, 2018
Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial
Stuart A Little, Jane Speight, Lalantha Leelarathna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2010
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer
Ramon Salazar, Paul Roepman, Gabriel Capella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2007
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group
Daniel J Sargent, Smitha Patiyil, Greg Yothers, et al.
Diabetes Care
|
May 24, 2014
Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS)
Stuart A Little, Lalantha Leelarathna, Emma Walkinshaw, et al.
Diabetes Care
|
November 22, 2014
Response to comment on Little et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-2122
Stuart A Little, Lalantha Leelarathna, Emma Walkinshaw, et al.
Cell Reports. Medicine
|
September 18, 2024
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer
Marta Nowak, Faiz Jabbar, Ann-Katrin Rodewald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database
Winson Y Cheung, Lindsay A Renfro, David Kerr, et al.
Diabetes Care
|
September 6, 2019
Predictors of Recurrent Severe Hypoglycemia in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia During the HypoCOMPaSS Study
Anneliese J S Flatt, Stuart A Little, Jane Speight, et al.
Page
of 32
Search research articles
Search
Showing results (251-260 of 315) with videos related to
Sort By:
Page
of 32
Journal of Diabetes Science and Technology
|
August 10, 2023
Use of Continuous Glucose Monitors in the Hospital: The Diabetes Technology Society Hospital Meeting Report 2023
Tiffany Tian, Rachel E Aaron, Andrea M Yeung, et al.
Molecular Systems Biology
|
November 5, 2017
Pharmacoproteomic characterisation of human colon and rectal cancer
Martin Frejno, Riccardo Zenezini Chiozzi, Mathias Wilhelm, et al.
Diabetes Care
|
April 18, 2018
Sustained Reduction in Severe Hypoglycemia in Adults With Type 1 Diabetes Complicated by Impaired Awareness of Hypoglycemia: Two-Year Follow-up in the HypoCOMPaSS Randomized Clinical Trial
Stuart A Little, Jane Speight, Lalantha Leelarathna, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 25, 2010
Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer
Ramon Salazar, Paul Roepman, Gabriel Capella, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 19, 2007
End points for colon cancer adjuvant trials: observations and recommendations based on individual patient data from 20,898 patients enrolled onto 18 randomized trials from the ACCENT Group
Daniel J Sargent, Smitha Patiyil, Greg Yothers, et al.
Diabetes Care
|
May 24, 2014
Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS)
Stuart A Little, Lalantha Leelarathna, Emma Walkinshaw, et al.
Diabetes Care
|
November 22, 2014
Response to comment on Little et al. Recovery of hypoglycemia awareness in long-standing type 1 diabetes: a multicenter 2 × 2 factorial randomized controlled trial comparing insulin pump with multiple daily injections and continuous with conventional glucose self-monitoring (HypoCOMPaSS). Diabetes Care 2014;37:2114-2122
Stuart A Little, Lalantha Leelarathna, Emma Walkinshaw, et al.
Cell Reports. Medicine
|
September 18, 2024
Single-cell AI-based detection and prognostic and predictive value of DNA mismatch repair deficiency in colorectal cancer
Marta Nowak, Faiz Jabbar, Ann-Katrin Rodewald, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 10, 2016
Determinants of Early Mortality Among 37,568 Patients With Colon Cancer Who Participated in 25 Clinical Trials From the Adjuvant Colon Cancer Endpoints Database
Winson Y Cheung, Lindsay A Renfro, David Kerr, et al.
Diabetes Care
|
September 6, 2019
Predictors of Recurrent Severe Hypoglycemia in Adults With Type 1 Diabetes and Impaired Awareness of Hypoglycemia During the HypoCOMPaSS Study
Anneliese J S Flatt, Stuart A Little, Jane Speight, et al.
Page
of 32